MabPlex International Announces Appointment of Dr. Wei Chen (Ph.D) as Chief Executive Officer
August 11, 2019

MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services

Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan has recognized MabPlex International Ltd. (MabPlex) with the 2019 Global Growth Excellence Leadership Award. Download Frost & Sullivan’s 11 page report.

Comments are closed.